Literature DB >> 212274

Influence of thyroid hormone on the positive inotropic effects mediated by alpha- and beta-adrenoceptors in isolated guinea pig atria and rabbit papillary muscles.

H Hashimoto, M Nakashima.   

Abstract

Effects of thyroxine treatment for 7--11 days on the positive inotropic effects mediated by alpha- and beta-adrenoceptors were studied in isolated guinea pig atria and rabbit papillary muscles. In guinea pig atria, the thyroxine treatment inhibited the positive inotropic effect of lower concentrations of phenylephrine (PHE), and attenuated the inhibitory effect of phentolamine on the PHE response. The effect of isoproterenol (ISO) was potentiated by the thyroxine treatment. In rabbit papillary muscles, the thyroxine treatment shifted the dose--response curve for PHE to the right and attenuated the inhibitory effect of phentolamine on the PHE response. Propranolol, in both guinea pig atria and rabbit papillary muscles, inhibited the PHE response more effectively in preparations from thyroxine-treated animals than in controls. In guinea peg atria, the attenuation of the PHE response mediated by alpha-adrenoceptors was observed after the thyroxine treatment for only 2 days, whereas the potentiation of the ISO response required the thyroxine treatment for a longer period. It was concluded that the thyroxine treatment attenuated the positive inotropic effect mediated by alpha-adrenoceptors and potentiated that mediated by beta-adrenoceptor-mediated positive inotropic effects due to the thyroxine treatment may be independent of each other.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 212274     DOI: 10.1016/0014-2999(78)90139-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  14 in total

Review 1.  [Alpha-adrenoceptors in the myocardium: incidence and functional significance].

Authors:  A Mügge
Journal:  Klin Wochenschr       Date:  1985-11-04

2.  Quantitative changes in beta-adrenergic responses of isolated atria from hyper- and hypothyroid rats.

Authors:  H P Rub; H Thommen; H Porzig
Journal:  Experientia       Date:  1981-04-15

3.  Influence of hypo- and hyperthyroidism on plasma catecholamines in pithed rats.

Authors:  M Nagel-Hiemke; G Gross; I Lues; H J Schümann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-09       Impact factor: 3.000

4.  A unique pressor response to isoprenaline in the pithed rat during triiodo-L-thyronine(T3)-induced hyperthyroidism.

Authors:  G Tsujimoto; K Hashimoto
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-10       Impact factor: 3.000

5.  Thyroid hormone modulates inotropic responses, alpha-adrenoceptor density and catecholamine concentrations in the rat heart.

Authors:  J Zwaveling; H D Batink; J de Jong; E A Winkler Prins; M Pfaffendorf; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-12       Impact factor: 3.000

6.  The influence of hormonal and neuronal factors on rat heart adrenoceptors.

Authors:  G Kunos; L Mucci; S O'Regan
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

7.  Mechanism of hyperthyroidism-induced modulation of the L-type Ca2+ current in guinea pig ventricular myocytes.

Authors:  S Mager; Y Palti; O Binah
Journal:  Pflugers Arch       Date:  1992-08       Impact factor: 3.657

8.  Age-dependent differences in the positive inotropic effect of phenylephrine on rat isolated atria.

Authors:  H Hashimoto; M Nakashima; N Sugino
Journal:  Br J Pharmacol       Date:  1983-06       Impact factor: 8.739

9.  Alterations of responsiveness to adrenoceptor agonists and calcium of non-infarcted hypertrophied muscles from rats with chronic myocardial infarction.

Authors:  T Itaya; H Hashimoto; T Uematsu; M Nakashima
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

10.  Additional evidence against universal modulation of beta-adrenoceptor responses by excessive thyroxine.

Authors:  S E Taylor
Journal:  Br J Pharmacol       Date:  1983-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.